Breaking News Instant updates and real-time market news.

AHH

Armada Hoffler

$8.22 /

-0.9 (-9.87%)

08:13
03/23/20
03/23
08:13
03/23/20
08:13

Armada Hoffler downgraded to Neutral from Buy at DA Davidson

DA Davidson analyst Barry Oxford downgraded Armada Hoffler to Neutral from Buy with a price target of $10, down from $12. The analyst notes that the company has an "impressive shopping center portfolio", but the viability of some of its tenants could come into question if stores stay closed for an extended period of time.

  • 30

    Apr

AHH Armada Hoffler
$8.22 /

-0.9 (-9.87%)

03/23/20 DA Davidson
Armada Hoffler downgraded to Neutral from Buy at DA Davidson

TODAY'S FREE FLY STORIES

Recommendations
Julius Baer price target lowered to EUR 49.50 from EUR 58.50 at Credit Suisse » 06:27
04/09/20
04/09
06:27
04/09/20
06:27
JBAXY

Julius Baer

$0.00 /

+ (+0.00%)

Credit Suisse analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
UBS price target lowered to EUR 13.50 from EUR 16 at Credit Suisse » 06:27
04/09/20
04/09
06:27
04/09/20
06:27
UBS

UBS

$9.60 /

+0.01 (+0.10%)

Credit Suisse analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Citi resumes coverage of Xerox with double downgrade to Sell » 06:25
04/09/20
04/09
06:25
04/09/20
06:25
XRX

Xerox

$19.26 /

+0.57 (+3.05%)

, HPQ

HP Inc.

$15.69 /

+0.59 (+3.91%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Securitas upgraded to Hold from Reduce at HSBC » 06:24
04/09/20
04/09
06:24
04/09/20
06:24
SCTBF

Securitas

$0.00 /

+ (+0.00%)

HSBC analyst Chirag…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Societe Generale upgraded to Neutral from Underperform at Credit Suisse » 06:23
04/09/20
04/09
06:23
04/09/20
06:23
SCGLY

Societe Generale

$0.00 /

+ (+0.00%)

Credit Suisse analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
HP Inc. resumed with a Neutral at Citi » 06:23
04/09/20
04/09
06:23
04/09/20
06:23
HPQ

HP Inc.

$15.69 /

+0.59 (+3.91%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
BNP Paribas entry point attractive, says Credit Suisse in upgrade to Outperform » 06:22
04/09/20
04/09
06:22
04/09/20
06:22
BNPQY

BNP Paribas

$0.00 /

+ (+0.00%)

Credit Suisse analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Mettler-Toledo downgraded to Underperform from In Line at Evercore ISI » 06:21
04/09/20
04/09
06:21
04/09/20
06:21
MTD

Mettler-Toledo

$741.96 /

+32.315 (+4.55%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Newmark double-downgraded to Underperform from Buy at BofA » 06:19
04/09/20
04/09
06:19
04/09/20
06:19
NMRK

Newmark

$3.76 /

+0.34 (+9.94%)

BofA analyst Michael Funk…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Capgemini reinstated with a Neutral at JPMorgan » 06:19
04/09/20
04/09
06:19
04/09/20
06:19
CGEMY

Capgemini

$0.00 /

+ (+0.00%)

JPMorgan analyst Stacy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CytoDyn: 7-day results from leronlimab treatment show immune restoration » 06:18
04/09/20
04/09
06:18
04/09/20
06:18
CYDY

CytoDyn

$0.00 /

+ (+0.00%)

CytoDyn announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Aon plc added to Focus List at Citi » 06:17
04/09/20
04/09
06:17
04/09/20
06:17
AON

Aon plc

$187.72 /

+11.72 (+6.66%)

Citi analyst Suneet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Barclays price target lowered to 125 GBp from 185 GBp at Credit Suisse » 06:17
04/09/20
04/09
06:17
04/09/20
06:17
BCS

Barclays

$4.56 /

+0.03 (+0.66%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Stereotaxis initiated with an Outperform at Cowen » 06:16
04/09/20
04/09
06:16
04/09/20
06:16
STXS

Stereotaxis

$2.72 /

-0.23 (-7.80%)

Cowen initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Zimmer Biomet downgraded to In Line from Outperform at Evercore ISI » 06:15
04/09/20
04/09
06:15
04/09/20
06:15
ZBH

Zimmer Biomet

$111.25 /

+9.32 (+9.14%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Starbucks assumed with a Buy at Citi » 06:15
04/09/20
04/09
06:15
04/09/20
06:15
SBUX

Starbucks

$71.49 /

+2.81 (+4.09%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Clovis downgraded to Underperform from Neutral at BofA » 06:15
04/09/20
04/09
06:15
04/09/20
06:15
CLVS

Clovis

$6.92 /

+0.16 (+2.37%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cognizant announces actions in response to COVID-19 pandemic » 06:14
04/09/20
04/09
06:14
04/09/20
06:14
CTSH

Cognizant

$51.37 /

+3.64 (+7.63%)

Cognizant has taken steps…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Lloyds Banking price target lowered to 40 GBp from 60 GBp at Credit Suisse » 06:13
04/09/20
04/09
06:13
04/09/20
06:13
LYG

Lloyds Banking

$1.52 /

+0.065 (+4.47%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Intuitive Surgical downgraded to Underperform from In Line at Evercore ISI » 06:13
04/09/20
04/09
06:13
04/09/20
06:13
ISRG

Intuitive Surgical

$512.23 /

+23.23 (+4.75%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Novocure downgraded to Underperform from In Line at Evercore ISI » 06:12
04/09/20
04/09
06:12
04/09/20
06:12
NVCR

Novocure

$69.39 /

+4.96 (+7.70%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
RBS price target lowered to 175 GBp from 260 GBp at Credit Suisse » 06:12
04/09/20
04/09
06:12
04/09/20
06:12
RBS

RBS

/

+

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Varian Medical downgraded to Underperform from Outperform at Evercore ISI » 06:12
04/09/20
04/09
06:12
04/09/20
06:12
VAR

Varian Medical

$114.77 /

+7.8 (+7.29%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Stitch Fix price target lowered to $11 from $15 at Piper Sandler » 06:12
04/09/20
04/09
06:12
04/09/20
06:12
SFIX

Stitch Fix

$13.53 /

+0.19 (+1.42%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cognizant withdraws FY20 guidance due to COVID-19 pandemic  06:11
04/09/20
04/09
06:11
04/09/20
06:11
CTSH

Cognizant

$51.37 /

+3.64 (+7.63%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.